Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp (SYK.US)$ with a hold rating, and adjusts the target price from $350 to $370.
According to TipRanks data, the analyst has a success rate of 37.7% and a total average return of -6.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Stryker Corp (SYK.US)$'s main analysts recently are as follows:
Stryker's recent financial results demonstrated a notable outperformance, characterized by 11.5% organic growth, robust double-digit expansion in the majority of its key businesses, and a higher than anticipated operating margin.
Stryker's Q3 outcomes surpassed expectations, showcasing double-digit growth in both revenue and earnings, in conjunction with an increase in operating margins.
Stryker's recent financial results showed a stronger than expected performance on the revenue front. Looking ahead to 2025, the company's growth is anticipated to be fueled by the introduction of new products, the positive impact from mergers and acquisitions with an estimated 7 deals in the pipeline contributing to growth, and the ongoing increase in utilization of Mako, particularly with the addition of two new indications. The analyst indicates maintaining a cautious stance until there is more certainty in sales and earnings per share surpassing market expectations.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析师Drew Ranieri维持$史赛克 (SYK.US)$持有评级，并将目标价从350美元上调至370美元。
根据TipRanks数据显示，该分析师近一年总胜率为37.7%，总平均回报率为-6.0%。
此外，综合报道，$史赛克 (SYK.US)$近期主要分析师观点如下：
Stryker最近的财务业绩显示出明显的跑赢大盘，其特点是11.5％的有机增长，其大多数关键业务实现了强劲的两位数扩张，营业利润率高于预期。
Stryker的第三季度业绩超出了预期，收入和收益均实现了两位数的增长，同时营业利润率也有所提高。
Stryker最近的财务业绩显示，收入方面的表现强于预期。展望2025年，预计该公司的增长将受到新产品的推出、合并和收购的积极影响（估计有7笔交易在进行中）推动增长，以及Mako利用率的持续提高，尤其是增加了两个新适应症。分析师表示，在销售额和每股收益超过市场预期的确定性之前，将保持谨慎立场。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
